Serum coenzyme Q10 levels are associated with coronary flow reserve in hemodialysis patients

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Hemodialysis international. International Symposium on Home Hemodialysis

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/hdi.12001PMID 23185999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• β-Blockers and Coronary Flow Reserve

  2012cited by this paper
• Olmesartan Improves Coronary Flow Reserve of Hypertensive Patients Using Coronary Magnetic Resonance Imaging Compared with Amlodipine

  2012cited by this paper
• Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials.

  2012cited by this paper
• Coenzyme Q10 and its Relation with Oxidant and Antioxidant System Markers in Patients with End-Stage Renal Disease

  2011cited by this paper
• Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy

  2010cited by this paper
• Endothelial dysfunction in hemodialysis patients with failed renal transplants

  2010cited by this paper
• Serum Biological Antioxidant Potential Predicts the Prognosis of Hemodialysis Patients

  2010cited by this paper
• Coronary artery calcification and coronary flow velocity in haemodialysis patients.

  2010cited by this paper
• Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.

  2009cited by this paper
• GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients.

  2009cited by this paper
• Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients

  2008cited by this paper
• Beta-blockers and coronary flow reserve: the importance of a vasodilatory action.

  2008cited by this paper
• Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis.

  2008cited by this paper
• The effect of carvedilol therapy on coronary flow reserve in patients with idiopathic dilated cardiomyopathy.

  2008cited by this paper
• Coenzyme Q10 Administration Suppresses both Oxidative and Antioxidative Markers in Hemodialysis Patients

  2008cited by this paper
• Enrichment of coenzyme Q10 in plasma and blood cells: defense against oxidative damage

  2007cited by this paper
• Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials

  2007cited by this paper
• Coenzyme Q10.

  2005cited by this paper
• Coronary flow reserve in stress-echo lab. From pathophysiologic toy to diagnostic tool

  2005cited by this paper
• Cardiovascular risk factors in chronic kidney disease.

  2005cited by this paper
• Traditional and emerging cardiovascular risk factors in end-stage renal disease.

  2003cited by this paper
• Pathology,Assessment and Treatment of Endothelial Dysfunction

  2003cited by this paper
• Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension.

  2002cited by this paper
• Randomized, Double-Blind, Placebo- Controlled Trial of Coenzyme Q10 in Isolated Systolic Hypertension

  2001cited by this paper
• 8-hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients.

  2000cited by this paper
• High-performance liquid chromatography-coulometric electrochemical detection of ubiquinol 10, ubiquinone 10, carotenoids, and tocopherols in neonatal plasma.

  1999cited by this paper
• Assessment and treatment of endothelial dysfunction in humans.

  1999cited by this paper
• Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color Doppler echocardiography.

  1998cited by this paper
• Low plasma ascorbic acid independently predicts the presence of an unstable coronary syndrome.

  1998cited by this paper
• Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men.

  1997cited by this paper
• Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy.

  1997cited by this paper
• Serum coenzyme Q10 in uremic patients on chronic hemodialysis.

  1994cited by this paper
• Cardiovascular risk factors in chronic renal failure and hemodialysis populations.

  1992cited by this paper
• Effects of coronary stenoses on coronary flow reserve and resistance.

  1974cited by this paper

• Evaluation of efficacy and safety of coenzyme Q10 in pediatric hemodialysis patients: a randomized controlled trial

  2025cites this paper
• A systematic review for the efficacy of coenzyme Q10 in patients with chronic kidney disease

  2021cites this paper
• Disorders of Human Coenzyme Q10 Metabolism: An Overview

  2020cites this paper
• Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview

  2019cites this paper
• The effect of coenzyme Q 10 on cognitive status in chronic hemodialysis patients ; a double-blind , randomized , clinical trial

  2018cites this paper
• Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients

  2018cites this paper
• Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial.

  2017cites this paper
• Koenzim Q ve Hastalıklar ile İlişkisi

  2016cites this paper
• Mitochondria: a new therapeutic target in chronic kidney disease

  2015cites this paper
• Epicardial fat tissue thickness is correlated with diminished levels of co-enzyme Q10, a major antioxidant molecule among hemodialysis patients.

  2014cites this paper
• Serum coenzyme Q10 levels and coronary flow reserve in hemodialysis patients

  2013cites this paper
• Coenzyme Q10 supplementation may improve diastolic heart functions especially coronary artery disease patients

  2013cites this paper